FreeStyle Libre 3 Recall: 7 Deaths Linked to Faulty Glucose Sensors

by Michael Brown - Business Editor
0 comments

Abbott laboratories initiated a global recall Wednesday of millions of FreeStyle Libre 3 and 3 Plus glucose sensors after reports of inaccurate readings possibly linked to adverse health events, including seven deaths [[1]].The recall, impacting users in seventeen countries, stems from sensors manufactured at a single facility that may underestimate blood glucose levels, posing a serious risk to individuals managing diabetes [[2]], [[3]]. Abbott is advising users to seek replacement sensors and temporarily rely on alternative glucose monitoring methods.

Abbott Laboratories announced Wednesday a widespread recall of its FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose sensors across seventeen countries, including the United States, France, and Belgium, following reports of a malfunction potentially linked to seven deaths.

The pharmaceutical company stated that internal testing revealed certain sensors may provide inaccurate low blood glucose readings. According to a company statement, they have received reports of 736 serious adverse events that could be related to the issue.

Continuous Glucose Monitoring

The recall impacts “certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus” sensors used by individuals managing diabetes. These devices are critical for continuous glucose monitoring, helping patients proactively avoid dangerous hypoglycemic or hyperglycemic episodes that can lead to coma or death.

Abbott clarified that the defective sensors originated from a single manufacturing facility and has since notified health authorities in all affected countries, initiating a recall process. The company’s shares were subject to modest downward pressure in early trading as investors assessed the potential financial and reputational impact of the recall.

Approximately 3 million faulty sensors are estimated to have been distributed in the United States alone, Abbott said. The recall underscores the importance of rigorous quality control in the medical device industry and the potential consequences of inaccuracies in health monitoring technology.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy